a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PAGHX | 99.37 | -0.21 | -0.21% |
Permanent Portfolio Aggressive Growth C | |||
LMEAX | 17.39 | -0.10 | -0.57% |
Franklin International Equity A | |||
PGLEX | 15.83 | -0.14 | -0.88% |
Putnam Focused International Equity R6 | |||
PRVIX | 59.73 | -0.56 | -0.93% |
T. Rowe Price Small-Cap Value I | |||
OSCYX | 24.06 | -0.33 | -1.35% |
Invesco Main Street Small Cap Y |
A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.
Ticker / NAME | Correlation To RLAY | 1D Price Change % | ||
---|---|---|---|---|
RLAY | 100% | -8.84% | ||
XNCR - RLAY | 56% Loosely correlated | -1.83% | ||
BCYC - RLAY | 46% Loosely correlated | -3.50% | ||
TVTX - RLAY | 45% Loosely correlated | -4.06% | ||
PGEN - RLAY | 45% Loosely correlated | -7.11% | ||
ABOS - RLAY | 45% Loosely correlated | -8.05% | ||
More |